GNC-038 Tetra-specific Antibody Injection

· Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GNC-038 Tetra-specific Antibody Injection, covering 2025-04-15 to 2025-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis [Phase 1]